pubmed-article:9865617 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:9865617 | lifeskim:mentions | umls-concept:C0005855 | lld:lifeskim |
pubmed-article:9865617 | lifeskim:mentions | umls-concept:C0035334 | lld:lifeskim |
pubmed-article:9865617 | lifeskim:mentions | umls-concept:C0271051 | lld:lifeskim |
pubmed-article:9865617 | lifeskim:mentions | umls-concept:C0000981 | lld:lifeskim |
pubmed-article:9865617 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:9865617 | lifeskim:mentions | umls-concept:C0060520 | lld:lifeskim |
pubmed-article:9865617 | lifeskim:mentions | umls-concept:C0005529 | lld:lifeskim |
pubmed-article:9865617 | lifeskim:mentions | umls-concept:C0231242 | lld:lifeskim |
pubmed-article:9865617 | pubmed:issue | 12 | lld:pubmed |
pubmed-article:9865617 | pubmed:dateCreated | 1999-3-16 | lld:pubmed |
pubmed-article:9865617 | pubmed:abstractText | The carbonic anhydrase inhibitor acetazolamide (AZM) reduces macular oedema in some patients with retinitis pigmentosa. To better understand the oedema-reducing effect of AZM, the effect of AZM on passive permeability and active transport of fluorescein across the blood-retina barrier was studied in patients with retinitis pigmentosa and varying degrees of macular oedema. | lld:pubmed |
pubmed-article:9865617 | pubmed:language | eng | lld:pubmed |
pubmed-article:9865617 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9865617 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:9865617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9865617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9865617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9865617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9865617 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:9865617 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:9865617 | pubmed:month | Dec | lld:pubmed |
pubmed-article:9865617 | pubmed:issn | 0721-832X | lld:pubmed |
pubmed-article:9865617 | pubmed:author | pubmed-author:LarsenMM | lld:pubmed |
pubmed-article:9865617 | pubmed:author | pubmed-author:RosenbergTT | lld:pubmed |
pubmed-article:9865617 | pubmed:author | pubmed-author:EnglerCC | lld:pubmed |
pubmed-article:9865617 | pubmed:author | pubmed-author:Lund-Andersen... | lld:pubmed |
pubmed-article:9865617 | pubmed:author | pubmed-author:MICC | lld:pubmed |
pubmed-article:9865617 | pubmed:author | pubmed-author:SanderBB | lld:pubmed |
pubmed-article:9865617 | pubmed:author | pubmed-author:MoldowBB | lld:pubmed |
pubmed-article:9865617 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:9865617 | pubmed:volume | 236 | lld:pubmed |
pubmed-article:9865617 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:9865617 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:9865617 | pubmed:pagination | 881-9 | lld:pubmed |
pubmed-article:9865617 | pubmed:dateRevised | 2007-11-15 | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:meshHeading | pubmed-meshheading:9865617-... | lld:pubmed |
pubmed-article:9865617 | pubmed:year | 1998 | lld:pubmed |
pubmed-article:9865617 | pubmed:articleTitle | The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. | lld:pubmed |
pubmed-article:9865617 | pubmed:affiliation | University of Copenhagen, Herlev Sygehus, Department of Ophthalmology, Denmark. | lld:pubmed |
pubmed-article:9865617 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:9865617 | pubmed:publicationType | Clinical Trial | lld:pubmed |
pubmed-article:9865617 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:9865617 | pubmed:publicationType | Randomized Controlled Trial | lld:pubmed |
pubmed-article:9865617 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9865617 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9865617 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9865617 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:9865617 | lld:pubmed |